Marykate Kratzer
Gastroenterology · Greenville, NCNPI 1841853439
Payments from drug & device makers
Across 106 payments — averaging $23.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$636
- Takeda Pharmaceuticals U.S.A., Inc.$376
- Intercept Pharmaceuticals, Inc.$311
- Johnson & Johnson$159
- Aimmune Therapeutics, Inc.$140
- Merck$86
- plus $784 from 20 others
What the payments were for
- Food & beverage$2,493100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $636 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $376 |
| Intercept Pharmaceuticals, Inc. | 10 | $311 |
| Johnson & Johnson | 7 | $159 |
| Aimmune Therapeutics, Inc. | 6 | $140 |
| Merck | 5 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $82 |
| Sanofi | 3 | $70 |
| Pfizer | 4 | $66 |
| Novo Nordisk | 3 | $63 |
| Madrigal Pharmaceuticals | 2 | $49 |
| Mirum Pharmaceuticals, Inc. | 2 | $45 |
| QOL Medical, LLC | 2 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $39 |
| Ardelyx, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $32 |
| Vivus LLC | 2 | $29 |
| Celltrion USA Inc. | 1 | $29 |
| Gilead | 1 | $23 |
| Boehringer Ingelheim | 1 | $20 |
| Olympus America Inc. | 1 | $17 |
| Sandoz | 1 | $15 |
| Biocon Biologics Inc | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,493 in reported general payments places this provider in the 50th percentile of 610 gastroenterology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 19 | $13,480 |
| Omeprazole | 53 | $683 |
| Esomeprazole Magnesium | 25 | $526 |
| Pantoprazole Sodium | 14 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $636 | $13,48019 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 610 gastroenterology providers in North Carolina.
Other gastroenterology in Greenville
- Phillip GoldsteinGreenville$1.4M
- Evan DellonChapel Hill$11.2M
- Andrew MuirDurham$6.6M
- Manal AbdelmalekDurham$5.6M
- Robert ReindollarSalisbury$2.5M
- John PoulosFayetteville$2.1M
- Hans HerfarthChapel Hill$2M
- Herbert BonkovskyWinston Salem$1.7M
- Ikechukwu IbegbuJacksonville$1.5M
- Nicholas ShaheenChapel Hill$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.